And that is all part of the unknown.
If pricing is going to be charged higher than competitor products, market penetration is going to take longer, and a certain group simply will not afford to change treatments because it is at a premium price.
Just because there are more sufferers does not mean they will all seek treatment.
One thing going for it is the fact it is not an injection, which might also be a positive for people not wanting to get botox , currently not being treated.
SOFDRA market size, page-20
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 32.0¢ | $3.160M | 9.427M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 670399 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 24177 | 3 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |